Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 23:S1094-7159(25)00190-4.
doi: 10.1016/j.neurom.2025.04.012. Online ahead of print.

Transcutaneous Cervical Vagus Nerve Stimulation Modulates Prefrontal Cortex Activity During Opioid Withdrawal in Individuals With Opioid Use Disorder

Affiliations

Transcutaneous Cervical Vagus Nerve Stimulation Modulates Prefrontal Cortex Activity During Opioid Withdrawal in Individuals With Opioid Use Disorder

Farhan N Rahman et al. Neuromodulation. .

Abstract

Background: Opioid use disorder (OUD) is associated with considerable morbidity and mortality with limited treatment approaches. Understanding brain mechanisms in response to treatment could be useful in guiding future developments in treatment approaches.

Objective: The purpose of this study was to assess the effects of transcutaneous cervical vagus nerve stimulation (tcVNS) on brain response to opioid use cues in patients with OUD in opioid withdrawal.

Materials and methods: Patients with OUD who were in the early stage of recovery and/or on medication underwent brain imaging with positron emission tomography and radiolabeled water in conjunction with stimulation with active tcVNS or sham devices and exposure to opioid-use-related cues.

Results: tcVNS caused a relative increase in function in the anterior cingulate, dorsal anterior cingulate, and left inferior frontal gyrus during exposure to opioid cues. There also was a pattern of increased activation in the ventral striatum and orbitofrontal cortex.

Conclusion: tcVNS modulates brain areas implicated in opioid addiction, suggesting a useful role as an adjunctive therapy for OUD.

Clinical trial registration: The Clinicaltrials.gov registration number for the study is NCT04556552.

Keywords: Noninvasive; opioid use disorder; prefrontal cortex; vagus nerve stimulation.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest James Douglas Bremner reports equipment, drugs, or supplies were provided by electroCore LLC (tcVNS and sham devices). The remaining authors reported no conflict of interest.

Similar articles

References

    1. Buchanich JM, Balmert LC, Williams KE, Burke DS. The effect of incomplete death certificates on estimates of unintentional opioid-related overdose deaths in the United States, 1999–2015. Public Health Rep. 2018;133:423–431. - PMC - PubMed
    1. U.S. overdose deaths decrease in 2023, first time since 2018. Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2024/20240515.htm; 2024. Accessed July 22, 2024.
    1. Spencer MR, Garnett M, Miniño AM. Drug overdose deaths in the United States, 2002–2022. US Department of Health and Human Services, Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/products/databriefs/db491.htm. Accessed July 22, 2024.
    1. FastStats. Centers for Disease Control and Prevention. https://web.archive.org/web/20240719122325/. Accessed July 22, 2024.
    1. Korf J, Bunney BS, Aghajanian GK. Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur J Pharmacol. 1974;25:165–169. - PubMed

Associated data

LinkOut - more resources